首页> 美国卫生研究院文献>BMC Endocrine Disorders >Graz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism
【2h】

Graz Endocrine Causes of Hypertension (GECOH) study: a diagnostic accuracy study of aldosterone to active renin ratio in screening for primary aldosteronism

机译:格拉茨高血压的内分泌原因研究(GECOH):筛查原发性醛固酮增多症的醛固酮与活性肾素比率的诊断准确性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPrimary aldosteronism (PA) affects approximately 5 to 10% of all patients with arterial hypertension and is associated with an excess rate of cardiovascular complications that can be significantly reduced by a targeted treatment. There exists a general consensus that the aldosterone to renin ratio should be used as a screening tool but valid data about the accuracy of the aldosterone to renin ratio in screening for PA are sparse. In the Graz endocrine causes of hypertension (GECOH) study we aim to prospectively evaluate diagnostic procedures for PA.
机译:背景:原发性醛固酮增多症(PA)会影响约5-10%的动脉高血压患者,并且与心血管并发症发生率过高有关,可以通过有针对性的治疗显着降低心血管并发症的发生率。人们普遍认为,应使用醛固酮与肾素的比率作为筛查工具,但有关筛查PA的醛固酮与肾素的比率的准确性的有效数据很少。在格拉茨高血压内分泌原因(GECOH)研究中,我们旨在前瞻性评估PA的诊断程序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号